Matinas Biopharma Holdings Inc. (MTNB) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Matinas Biopharma Holdings Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.91
+4.37% today
Market cap
$2M
Overall quality
—
Kronos AI 30-day
+66.5%
8 of 8 simulated paths end higher
Matinas Biopharma Holdings Inc. (MTNB) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $2M. It trades at $1.91, up 4.37% today. Kronos AI's 30-day forecast is +66.5% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $3.05 (+66.5%) |
| Likely range | +45.8% … +104.9% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.